E854-5150 Screening compound: N-(3,4-dimethoxyphenyl)-2-[3,4-dimethyl-2-(4-methylphenyl)-7-oxo-2H,6H,7H-pyrazolo[3,4-d]pyridazin-6-yl]butanamide

E854-5150 Screening compound: N-(3,4-dimethoxyphenyl)-2-[3,4-dimethyl-2-(4-methylphenyl)-7-oxo-2H,6H,7H-pyrazolo[3,4-d]pyridazin-6-yl]butanamide
E854-5150 Screening compound: N-(3,4-dimethoxyphenyl)-2-[3,4-dimethyl-2-(4-methylphenyl)-7-oxo-2H,6H,7H-pyrazolo[3,4-d]pyridazin-6-yl]butanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E854-5150
N-(3,4-dimethoxyphenyl)-2-[3,4-dimethyl-2-(4-methylphenyl)-7-oxo-2H,6H,7H-pyrazolo[3,4-d]pyridazin-6-yl]butanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E854-5150

Molecular Formula

C26H29N5O4 (C26 H29 N5 O4)

Compound Name

N-(3,4-dimethoxyphenyl)-2-[3,4-dimethyl-2-(4-methylphenyl)-7-oxo-2H,6H,7H-pyrazolo[3,4-d]pyridazin-6-yl]butanamide

IUPAC name

N-(34-dimethoxyphenyl)-2-[34-dimethyl-2-(4-methylphenyl)-7-oxo-2H6H7H-pyrazolo[34-d]pyridazin-6-yl]butanamide

SMILES

CCC(C(Nc(cc1)cc(OC)c1OC)=O)N1N=C(C)c2c(C)n(-c3ccc(C)cc3)nc2C1=O

InChI

InChI=1S/C26H29N5O4/c1-7-20(25(32)27-18-10-13-21(34-5)22(14-18)35-6)31-26(33)24-23(16(3)28-31)17(4)30(29-24)19-11-8-15(2)9-12-19/h8-14,20H,7H2,1-6H3,(H,27,32)/t20-/m0/s1

InChI Key

DXRHNSDNCNKALY-FQEVSTJZSA-N

MDL Number (MFCD)

MFCD14923125

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

475.55

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.889

Distribution Coefficient, logD

3.889

Water Solubility, LogSw

-4.17

Polar Surface Area

78.084

Acid Dissociation Constant (pKa)

11.36

Base Dissociation Constant (pKb)

2.81

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

30.80

E854-5150 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Protein-Protein Interaction Library (218420 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
Targets:
  • GPCR

References: we are preparing a list of scientific research reports with E854-5150 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E854-5150?
Check Price and Availability of E854-5150, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E854-5150 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E854-5150
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E854-5150
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E854-5150 available by request